<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00397462</url>
  </required_header>
  <id_info>
    <org_study_id>CSERC-005</org_study_id>
    <nct_id>NCT00397462</nct_id>
  </id_info>
  <brief_title>Blood Flow and Bone Density in Healthy Adult Women</brief_title>
  <official_title>Blood Flow and Bone Density in Healthy Adult Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Binghamton University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Juvent, Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>New york State Office of Science Technology and Academic Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Binghamton University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project will test the efficacy of using a non-invasive neuromuscular stimulation on the
      plantar surface of the feet to prevent and/ or reverse bone loss in a sample of healthy adult
      women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women between the ages of 30 and 60 years of age who work in positions that require them to
      be seated at desks for a large portion of each day, are capable of following the protocol for
      one year, have a t-score &gt;- 2.5 (do not have osteoporosis), and respond to plantar
      stimulation will be asked to participate. Women will be excluded who are receiving
      medications for osteoporosis, taking hormone replacement therapy, taking steroids (either
      oral or inhaled), have metal implants in the tibia, hip and spine that interfere with DEXA
      (bone density) scanning, are professional or semi-professional athletes, have
      hyperparathyroidism, have a history of pulmonary embolism, deep vein thrombosis, peripheral
      vascular disease or varicose veins, have a Body Mass Index greater than 40 Kg/m2, have any
      type of neuromuscular disease, or are pregnant . Once the inclusion and exclusion criteria
      are met, 45 subjects will be randomized into 3 groups including 1) a group of 15 subjects who
      will use the device (stimulation) for up to 4 hours a day, 2) a group of 15 subjects that
      will use the device for up to 8 hours a day, and 3) a control group who will not use the
      device. Subjects in the two treatment groups will be asked to place their feet on a
      mechanical device that will deliver a slight vibration while they are seated at work.
      Vibrations between 30-60 Hz has been shown to stimulate the Meissner's corpuscles which in
      turn stimulate contraction of the deep muscles of the calves. This contraction has been shown
      to increase venous and lymphatic return from the lower extremities thus improve bone
      metabolism. Bone density readings and venous circulation will be measured at the onset of
      this research and will be repeated after 12 months of using the device.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone Density of Proximal Femur</measure>
    <time_frame>One year</time_frame>
    <description>Proximal femur bone mineral density by dual energy x-ray absorptiometry (DXA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proximal Tibia Bone Density</measure>
    <time_frame>One year</time_frame>
    <description>Proximal tibia bone mineral density by dual energy x-ray absorptiometry (DXA)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Bone Loss</condition>
  <condition>Hypotensive</condition>
  <condition>Lower Limb Fluid Pooling</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No change to usual behavior</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Request that calf muscle pump stimulation be used less than four hours per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Request that calf muscle pump stimulation be used at least four hours per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>calf muscle pump stimulation</intervention_name>
    <description>Micromechanical stimulation of the postural reflex arc to activate the soleus muscle to enhance lower limb fluid return to the heart</description>
    <arm_group_label>Low dose</arm_group_label>
    <arm_group_label>High dose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy women 30 - 60 years old

          -  work in seated positions

        Exclusion Criteria:

          -  weigh more than 350 pounds

          -  pregnant or plan to become pregnant

          -  professional athlete

          -  currently on Hormone Replacement Therapy

          -  currently taking medication for osteoporosis

          -  currently on corticosteroids

          -  metal implants in tibia hip spine forearm

          -  diagnosed with hyperparathyroidism

          -  diagnosed with neuromuscular disease

          -  pulmonary embolism

          -  deep vein thrombosis

          -  peripheral vascular disease

          -  medications for hypertension
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth McLeod, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Binghamton University SUNY, BioEngineering</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2006</study_first_submitted>
  <study_first_submitted_qc>November 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2006</study_first_posted>
  <results_first_submitted>July 22, 2016</results_first_submitted>
  <results_first_submitted_qc>September 15, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 26, 2016</results_first_posted>
  <last_update_submitted>September 15, 2016</last_update_submitted>
  <last_update_submitted_qc>September 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Binghamton University</investigator_affiliation>
    <investigator_full_name>Kenneth McLeod</investigator_full_name>
    <investigator_title>Professor, BioEngineering</investigator_title>
  </responsible_party>
  <keyword>Osteoporosis</keyword>
  <keyword>Sarcopenia</keyword>
  <keyword>Calf muscle pump</keyword>
  <keyword>Venous insufficiency</keyword>
  <keyword>DEXA</keyword>
  <keyword>Soleus muscle</keyword>
  <keyword>APG</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Group 1 Low Use</title>
          <description>requested that they use the intervention during only the morning or afternoon up to 4 hours</description>
        </group>
        <group group_id="P2">
          <title>Group 2 High Use</title>
          <description>requested that they use the intervention as much as possible during the work day</description>
        </group>
        <group group_id="P3">
          <title>Control</title>
          <description>No intervention</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group 1 Low Use</title>
          <description>requested that they use the intervention during only the morning or afternoon up to 4 hours</description>
        </group>
        <group group_id="B2">
          <title>Group 2 High Use</title>
          <description>requested that they use the intervention as much as possible during the work day</description>
        </group>
        <group group_id="B3">
          <title>Control</title>
          <description>No use of the intervention</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
            <count group_id="B2" value="13"/>
            <count group_id="B3" value="15"/>
            <count group_id="B4" value="44"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.9" spread="8.1"/>
                    <measurement group_id="B2" value="44.8" spread="9.1"/>
                    <measurement group_id="B3" value="44.5" spread="8.1"/>
                    <measurement group_id="B4" value="45.8" spread="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Bone Density of Proximal Femur</title>
        <description>Proximal femur bone mineral density by dual energy x-ray absorptiometry (DXA)</description>
        <time_frame>One year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>No change to usual behavior</description>
          </group>
          <group group_id="O2">
            <title>Low Dose</title>
            <description>Request that calf muscle pump stimulation be used less than four hours per day
calf muscle pump stimulation: Micromechanical stimulation of the postural reflex arc to activate the soleus muscle to enhance lower limb fluid return to the heart</description>
          </group>
          <group group_id="O3">
            <title>High Dose</title>
            <description>Request that calf muscle pump stimulation be used at least four hours per day
calf muscle pump stimulation: Micromechanical stimulation of the postural reflex arc to activate the soleus muscle to enhance lower limb fluid return to the heart</description>
          </group>
        </group_list>
        <measure>
          <title>Bone Density of Proximal Femur</title>
          <description>Proximal femur bone mineral density by dual energy x-ray absorptiometry (DXA)</description>
          <units>percent change in bone density</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.133" spread=".370"/>
                    <measurement group_id="O2" value="-.675" spread=".437"/>
                    <measurement group_id="O3" value="1.3" spread="0.382"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Proximal Tibia Bone Density</title>
        <description>Proximal tibia bone mineral density by dual energy x-ray absorptiometry (DXA)</description>
        <time_frame>One year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>No change to usual behavior</description>
          </group>
          <group group_id="O2">
            <title>Low Dose</title>
            <description>Request that calf muscle pump stimulation be used less than four hours per day
calf muscle pump stimulation: Micromechanical stimulation of the postural reflex arc to activate the soleus muscle to enhance lower limb fluid return to the heart</description>
          </group>
          <group group_id="O3">
            <title>High Dose</title>
            <description>Request that calf muscle pump stimulation be used at least four hours per day
calf muscle pump stimulation: Micromechanical stimulation of the postural reflex arc to activate the soleus muscle to enhance lower limb fluid return to the heart</description>
          </group>
        </group_list>
        <measure>
          <title>Proximal Tibia Bone Density</title>
          <description>Proximal tibia bone mineral density by dual energy x-ray absorptiometry (DXA)</description>
          <units>percent change in bone density</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.14" spread="1.14"/>
                    <measurement group_id="O2" value="-2.111" spread=".64"/>
                    <measurement group_id="O3" value="1.65" spread=".56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Group 1 Low Use</title>
          <description>requested that they use the intervention during only the morning or afternoon up to 4 hours</description>
        </group>
        <group group_id="E2">
          <title>Group 2 High Use</title>
          <description>requested that they use the intervention as much as possible during the work day</description>
        </group>
        <group group_id="E3">
          <title>Control</title>
          <description>did not use the intervention</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Professor Kenneth McLeod</name_or_title>
      <organization>Binghamton University, SUNY</organization>
      <phone>(607)777-5779</phone>
      <email>kmcleod@binghamton.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

